Clinical Trial Update: Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation [NA]

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating darbepoetin alfa (Aranesp) following allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Darbepoetin alfa (Aranesp) (darbepoetin alfa)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Hematologic Malignancies | NA | Status: COMPLETED